首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1373377

全球傷口敷料市場 - 2023-2030

Global Wound Dressing Market - 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

傷口敷料清潔、覆蓋並保護傷口免受外部環境的影響。它必須提供潮濕的環境，去除多餘的滲出物，避免浸漬，保護損傷免受感染，並保持足夠的氣體交換。

選擇傷口敷料是為了控制滲出物、保護傷口和緩解疼痛。敷料或敷料是敷在傷口上的無菌墊，可促進癒合並保護傷口免受進一步傷害。現代敷料包括乾燥或浸漬紗布、塑膠薄膜、凝膠、泡沫、水膠體、藻酸鹽、水凝膠和多醣糊劑、顆粒和珠子。

市場動態：促進因素與限制因素

與傷口敷料相關的研究和投資活動不斷增加

公司為提供先進的傷口敷料和傷口護理而增加的投資預計將推動市場成長。新產品上市和批准的增加預計也將推動市場成長。

例如，2023 年 5 月 24 日，傷口管理公司 RedDress 在 D 輪融資中籌集了 2,600 萬美元，以繼續開發利用人體血液啟動傷口癒合過程的技術。本輪融資由 ATHOS Biopharma GmbH 等投資者參與，使該公司的總資金達到 4,300 萬美元。

此外，2021 年 5 月 14 日，Healogics 發布了一項新的 2.4 億美元股權投資，使該公司能夠繼續發展成為以患者為中心的領先傷口護理中心營運商。

克制

與傷口敷料相關的高成本

先進傷口敷料的高成本預計將阻礙市場成長。壓瘡治療的直接費用在 2,000 美元到 20,000 美元之間。

有關此報告的更多詳細資訊 - 索取樣本

Wound dressings are chosen to address exudate control, wound protection, and pain relief. A dressing or compress is a sterile pad applied to a wound to promote healing and protect the wound from further harm. Modern dressings include dry or impregnated gauze, plastic films, gels, foams, hydrocolloids, alginates, hydrogels, and polysaccharide pastes, granules, and beads.

Market Dynamics: Drivers & Restraints

Rising research & investment activities related to wound dressing

The increase in the investments by the companies in order to provide advanced wound dressing and wound care is expected to drive market growth. The increase in the product launches and approvals of the new products is also expected to drive the market growth.

For instance, on May 24, 2023, Wound management company RedDress raised $26m in a Series D financing round to continue developing its technology that harnesses human blood to jump-start the wound healing process. The round, which received participation from investors including ATHOS Biopharma GmbH, brings the company's total funding to $43m.

Additionally, on May 14, 2021, Healogics released a new $240 million equity investment, positioning the Company to continue its growth as a leading patient-centric wound care center operator.

Restraint

High costs associated with the wound dressings

The high cost associated with advanced wound dressing is expected to hamper the market growth. The direct costs for pressure ulcer treatment range between $2,000 and $20,000.

For more details on this report - Request for Sample

Segment Analysis

The global wound dressing market is segmented based on product type, material type, wound type, end-user and region.

Chronic wounds segment accounted for 45.3% of the market share

Chronic wounds segment is expected to hold a significant position in the market position. The increase in chronic wound burdens such as diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations is expected to increase the demand for wound dressing and thus increase segment growth.

For instance, according to the report issued by Mission Regional Medical Center in 2022, more than 29 million people (9.5% of the population) have diabetes in the United States (US) and almost two million of those people annually will develop a diabetic foot ulcer or other non-healing wound.

Additionally, according to the report by the National Institute of Health in 2023, over 6.7 million people in the United States alone suffer from chronic nonhealing wounds including diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations.

Geographical Analysis

North America is expected to hold a significant position in the global wound dressing market share

North American region accounted for the largest market share. The increase in the number of product launches, the presence of the major players in the region, and improved healthcare infrastructure in the region are expected to hold the region in the dominant market share.

For instance, on December 8, 2022, NEXGEL Inc. launched a unique hydrogel dressing, called Turfguard, for treating painful turf burns and protecting sports-related wounds.

Additionally, on August 11, 2022, DrySee launched a patented waterproof bandage with a liquid intrusion alert to users and caregivers when water or other liquids have penetrated the bandage. Thus, introducing new products and approvals is expected to drive the market growth in the region.

COVID-19 Impact Analysis:

COVID-19 pandemic was expected to lower the use of advanced wound dressing, as they require healthcare advice, thereby restricting the market's growth. The disruption in the supply chains and closure of the hospitals have affected the market growth negatively.

Competitive Landscape

The leading companies with a significant market share include: 3M Company, Dukal Corporation, Integra Lifesciences Holdings Corporation, Medline Industries Inc., Mckesson Corporation, Acelity L.P. Inc., Molnlycke Health Care, Coloplast Corp., Argentum Medical LLC, Urgo Medical among others.

Key Developments

On 3 January 2023, Convatec launched ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients.
On October 18, 2023, DuPont launched a new soft skin adhesive for wound care dressings. The non-sensitizing, non-irritating, and non-cytotoxic adhesive helps to protect the highly sensitive and fragile skin.

Why Purchase the Report?

To visualize the global wound dressing market segmentation based on product type, material type, wound type, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of wound dressing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global wound dressing market report would provide approximately 69 tables, 71 figures, and 183 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material Type
3.3. Snippet by Wound Type
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising research & investment activities related to wound dressing
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. High costs associated with the wound dressings
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Traditional Wound Dressing *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Gauze Dressing
- 7.2.4. Lint
- 7.2.5. Plasters
- 7.2.6. Bandages
- 7.2.7. Cotton Wool
7.3. Modern Wound Dressing
- 7.3.1. Passive Products
- 7.3.2. Interactive Products
- 7.3.3. Bioactive Products
- 7.3.4. Bioactive Wound Dressing
- 7.3.5. Tissue-Engineered Skin Substitutes
- 7.3.6. Medicated Dressing
- 7.3.7. Composite Dressing

8. By Material Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 8.1.2. Market Attractiveness Index, By Material Type
8.2. Hydrocolloid *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hydrogel
8.4. Collagen
8.5. Alginate
8.6. Foam
8.7. Transparent
8.8. Cloth

9. By Wound Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 9.1.2. Market Attractiveness Index, By Wound Type
9.2. Chronic Wounds *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Diabetic foot Ulcers
- 9.2.4. Pressure Ulcers
- 9.2.5. Venous Ulcers
- 9.2.6. Others
9.3. Acute Wounds
- 9.3.1. Surgical wounds
- 9.3.2. Traumatic wounds
- 9.3.3. Burns

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Research Organizations
10.5. Trauma Centers
10.6. Community Healthcare Centers
10.7. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Abbott Laboratories *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. BioMerieux SA
13.3. EKF Diagnostics Holdings plc
13.4. Atlas Medical
13.5. Quidel Corporation
13.6. BIOSYNEX SA
13.7. NG BIOTECH SAS
13.8. Axis Medicare
13.9. Cardinal Health Inc.
13.10. Thermo Fisher Scientific Inc.